Join us Oct 23 to focus on a bold new vision for geriatric depression care
1-day conference for health and human service professionals featuring evidence-based information about effective late-life depression treatment
Caring for community-dwelling older adults with depression is challenging and complicated by the presence of multiple chronic conditions. Yet evidence-based data on the success of community outreach for geriatric depression indicates that 80% is treatable. At this first-of-its-kind 1-day conference, mental health and human service professionals will learn about the latest evidence-based models and methods in community-based approaches that improve the quality of older adults’ lives.
What: Evidence-Based Community Interventions for Geriatric Depression, a 1-day conference
When: Oct 23
Where: Wisconsin Institutes for Discovery, Madison, WI (map)
Who the conference is for: Mental health and human services professionals serving aging adults
Why this conference: First-of-its-kind event highlighting effective evidence-based models and methods that improve quality of later life
Continuing education credit: 0.65 CEUs (6.5 hours)
Why this conference?
A bold new vision with evidence-basis is needed for community outreach and treatment of geriatric depression. According to the Centers for Disease Control Issue Brief #2 on geriatric depression (2009): “Behavioral Risk Factor Surveillance Data indicated that among adults age 50 or older, 7.7% reported current depression and 15.7% reported a lifetime diagnosis of depression.” Caring for community-dwelling older adults with depression is challenging and complicated by the presence of multiple chronic conditions. Evidence-based data on the success of community outreach for geriatric depression indicates that 80% of geriatric depression is treatable (Snowden, 2008). Health and human service professionals now have an opportunity to learn about collaborative, inter-professional approaches to geriatric depression care in this one-day conference at UW-Madison.
This first-of-its-kind regional conference on community interventions for geriatric depression will highlight effective evidence-based models and methods that improve quality of life.
You will learn about the nationally recognized PEARLS project( Program to Encourage an Active, Rewarding Life for Seniors), an evidence-based community program to reduce depression in physically impaired older adults. Dr. Mark Snowden, geriatric psychiatrist and director of PEARLS in Seattle, will present the morning keynote address and guide you through the components of PEARLS. He will also discuss how to tailor the program for the people of your own community.
Mark Snowden (MD, MPH) is Associate Professor of Psychiatry and Behavioral Sciences at the University of Washington in Seattle. In addition to his academic work he is the Medical Director for Geriatric Psychiatry Services at Seattle’s Harborview Medical Center. He is also board certified in Geriatric Psychiatry and is the principal investigator for the dissemination and implementation of the PEARLS Project. Doctor Snowden supervises geriatric psychiatry services for several community-based nursing homes and clinics. He has published extensively on care and treatment of late-life mental illness and community-based geriatric depression care.
Dr. Antonette Zeiss (PhD, Clinical Psychology) has conducted extensive research in late life mental disorders at the Veterans Administration's Central Office. During the course of her 30-year career at the VA she most notably focused her work on mental health policy and training, interdisciplinary teams and health care service delivery, and depression treatment and risk factors. She has received numerous awards throughout her career, including a U.S. Presidential Rank Award, Meritorious, for her service as a government senior executive; a Lifetime Achievement Award from the Association for Behavioral and Cognitive Therapies; and a Lifetime Achievement Award from the American Psychological Association, to be presented at their convention in July 2013. She has also served as a faculty member at Arizona State University and Stanford University.
Suzanna Waters Castillo (PhD, MSSW) is Faculty Associate and Instructor, programs on aging and community health, UW-Madison Continuing Studies.
Joseph Goveas (MD) is Board Certified Geriatric Psychiatrist, Clinical Professor at Wisconsin College of Medicine, Milwaukee, WI.
Ann Lewis is LPC for the Pilot Project on behavioral activation for older adults at Family Service Madison.
Target audience and scope of practice
This conference is designed for:
- Physicians and nurses
- Psychologists and psychotherapists, including clinicians
- Social workers
- Occupational, speech, and physical therapists
- Other health and human service professionals interested in learning the most current evidence-based approaches to community-based geriatric depression care
Elements of competence
The conference focuses on the American Board of Medical Specialties areas of medical knowledge as well as patient care and procedural skills.
Learning outcomes you’ll take away from the conference
- Define the components of evidence-based practice in geriatric depression care and the value of a problem-solving approach
- Discuss the community-based approach used by the PEARLS project
- Understand the purpose and therapeutic process of behavioral activation
- Know the purpose and application of the PhQ9 as a screening/ monitoring tool
- Identify how physicians and community-based providers can best collaborate on the status of their clients’ mental health
- Recognize the seminal role of collaboration and an integrated approach to community-based geriatric depression care
Policy on faculty and sponsor disclosure
It is the policy of the UW School of Medicine and Public Health that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.